UBS Group Has Lowered Expectations for Moderna (NASDAQ:MRNA) Stock Price
Moderna (NASDAQ:MRNA – Get Free Report) had its target price decreased by investment analysts at UBS Group from $96.00 to $78.00 in a research note issued to investors on Wednesday,Benzinga reports. The firm presently has a “buy” rating on the stock. UBS Group’s target price indicates a potential upside of 131.25% from the company’s previous […]
Moderna (NASDAQ:MRNA – Get Free Report) had its target price decreased by investment analysts at UBS Group from $96.00 to $78.00 in a research note issued to investors on Wednesday,Benzinga reports. The firm presently has a “buy” rating on the stock. UBS Group’s target price indicates a potential upside of 131.25% from the company’s previous […]
